Hemogenyx Pharmaceuticals
Company

Hemogenyx Pharmaceuticals

Biotechnology Research 1361 Amsterdam Ave 5 employees
Employees
5
Contacts
1
Emails
1
Phones
1

Hemogenyx Pharmaceuticals Overview

Headquarters
1361 Amsterdam Ave
Industry
Biotechnology Research
Employees
5
Founded
2013
Funding
333.5K
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Hemogenyx Pharmaceuticals

Hemogenyx Pharmaceuticals is a publicly traded company (LSE: HEMO) headquartered in London, with its US operating subsidiaries, Hemogenyx Pharmaceuticals LLC and Immugenyx LLC, located in New York City at its state-of-the-art research facility. The Company is a clinical-stage biopharmaceutical group developing new medicines and treatments for life-threatening diseases. Hemogenyx Pharmaceuticals is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.

Hemogenyx Pharmaceuticals Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage
Phone contacts
1
25.0% coverage

Hemogenyx Pharmaceuticals Org Chart

Sample employees and titles
Name Title Contact
Alan Walts Venture Partner at Advent Life Sciences
View
Elina Shrestha, Phd Director of Preclinical Development at Hemogenyx Pharmaceuticals Cell and Gene Therapy - Biologics
View
Paula Fernandez Musso Research Associate
View
Vladislav Sandler Scientist, Entrepreneur, Co-founder & CEO @ Hemogenyx Pharmaceuticals Plc - Phd, Neuroscience, Synthetic Biology, Tikkun Olam “Kindness to the Cruel
Email Phone

Employees by Management Level

Executive 1 profile
Director 1 profile
Individual contributor 1 profile
Associate / junior 1 profile

Compare Similar Companies to Hemogenyx Pharmaceuticals